Gene Discovery May Lead to Better Alzheimer's Treatments
THURSDAY, April 11, 2024 -- The discovery of a gene variant that rids the brain of toxic plaques linked to Alzheimer ' s might lead to new treatments for the disease, researchers report.
The variant arises naturally in people who don ' t seem to get... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 11, 2024 Category: General Medicine Source Type: news
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
The Elecsys ® pTau217 plasma biomarker test is being developed as part of an ongoing partnership between Roche and Eli Lilly and CompanyOnce approved, the test will aid healthcare providers in identifying amyloid pathology, a key feature of Alzheimer ’s diseaseRoche and Lilly believe the test could play an important role in improving access to early and accurate Alzheimer ’s diagnosisBasel, 11 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This blood test, which is being developed ...
Source: Roche Investor Update - April 11, 2024 Category: Pharmaceuticals Source Type: news
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
The Elecsys ® pTau217 plasma biomarker test is being developed as part of an ongoing partnership between Roche and Eli Lilly and CompanyOnce approved, the test will aid healthcare providers in identifying amyloid pathology, a key feature of Alzheimer ’s diseaseRoche and Lilly believe the test could play an important role in improving access to early and accurate Alzheimer ’s diagnosisBasel, 11 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This blood test, which is being developed ...
Source: Roche Media News - April 11, 2024 Category: Pharmaceuticals Source Type: news
Joseph E. Gaugler, Ph.D. to be Honored as the 2024 Distinguished Ambassador in Aging by the Aging Life Care Association ®
Dr. Joseph E. Gaugler will be presented with the 2024 Distinguished Ambassador in Aging award by the Aging Life Care Association® during the association's 40th annual conference in Minneapolis, MN. He will be recognized following his keynote address "Alzheimer's Disease Update: Testing,... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 11, 2024 Category: Pharmaceuticals Tags: PER Source Type: news
This vitamin deficiency can cause forgetfulness and mimic symptoms of dementia
About 5.8 million people in the U.S. have Alzheimer's disease and related dementias, giving these life-altering illnesses a wide impact across the country. But while it can be devastating when a loved one shows signs of memory loss, doctors say you shouldn’t automatically assume they have…#b12 #vitaminb12 #scottkaiser #santamonica #nih #deborahcohen #dcn #crohn #amitsachdev #kaiser (Source: Reuters: Health)
Source: Reuters: Health - April 11, 2024 Category: Consumer Health News Source Type: news
Alzheimer's: Medicines help manage symptoms and slow decline
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - April 11, 2024 Category: Consumer Health News Source Type: news
Researchers used the world's most powerful MRI to get brain scans that are 10 times as detailed as a hospital MRI
None French researchers used a powerful MRI machine to create detailed brain scans of about 20 people. • None The images are nearly 10 times more detailed than a hospital MRI's scans. • None The high-resolution images could provide insights into diseases like Alzheimer's and Parkinson's.…#iseult #alexandrevignaud #agencefrancepresse #teslas #dukeuniversity #tesla #clevelandclinic (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2024 Category: Consumer Health News Source Type: news
MRI links hearing loss to increased dementia risk
MRI has shown that hearing loss may increase dementia risk in seniors not yet cognitively impaired in ways distinct from those that tend to be associated with conditions such as Alzheimer's and cerebrovascular disease.A team led by Thomas Parker, MD, of the Imperial College London in the U.K. found that, compared with older adults who did not have hearing impairment, those who did had faster rates of whole brain atrophy. The findings were published April 3 in the Journal of Neurology, Neurosurgery and Psychiatry."Our data suggest a complex interplay of hearing ability, neurodegeneration, and cognition and implicate pathway...
Source: AuntMinnie.com Headlines - April 10, 2024 Category: Radiology Authors: Kate Madden Yee Tags: Subspecialties Neuroradiology Source Type: news
Can AI improve sustainability in nuclear medicine?
Nuclear medicine experts support the use of AI to improve sustainability of practices in the field, yet said implementation will require careful consideration of the technology’s benefits and detriments, according to an article published April 6 in Radiography.
Lead author Geoff Currie, PhD, of Charles Sturt University in New South Wales, Australia, and U.S. colleagues, discussed the potential for AI across what they describe as the “five pillars” of sustainability in nuclear medicine (social, human, economic, ecological, and environmental) and noted its benefits and threats in each pillar.
“AI, digital twins, an...
Source: AuntMinnie.com Headlines - April 9, 2024 Category: Radiology Tags: Nuclear Medicine Artificial Intelligence Source Type: news
Suicide overtakes dementia to become eighth leading cause of death in men: New CDC data reveals America's biggest killers
The CDC found suicide was the eighth leading cause of death in men in 2021, with 38,400 deaths per year, while Alzheimer's was ninth at 37,000 fatalities. (Source: the Mail online | Health)
Source: the Mail online | Health - April 8, 2024 Category: Consumer Health News Source Type: news
Botulism After 'Botox'? NEJM Ignored Nazi Atrocities; Jungle Jack's Alzheimer's
(MedPage Today) -- Note that some links may require registration or subscription.
The Tennessee Department of Health said it's collaborating with the CDC and FDA to investigate botulism-like symptoms in people who received Botox-like botulinum... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 8, 2024 Category: Psychiatry Source Type: news
Comparing survival rates and mortality in operative versus nonoperative treatment for femoral neck fractures among Alzheimer's disease patients: a retrospective cohort study - Yang Y, Drake SA, Wang J, Shen GC, Miao H, Morgan RO, Du XL, Lairson DR.
INTRODUCTION: Addressing femoral neck fractures resulting from ground-level falls in older adults with Alzheimer's disease (AD) involves a personalized treatment plan. There is considerable ongoing debate concerning the relative advantages and disadvantage... (Source: SafetyLit)
Source: SafetyLit - April 8, 2024 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
After life-changing losses, these millennials are now trying to help others preserve their loved ones' legacy
It wasn't until he became a father that Nicholas Worley rekindled the idea of preserving memories of his loved ones and their legacies. That idea first germinated when Worley was just 16. He lost his paternal grandfather to prostate cancer and his maternal grandmother to Alzheimer's that same year…#nicholasworley #britishcolombian #inalife #hongkong #singaporean #hareshtilani #terencechia #whartonschool #singapore #singaporeans (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news
Roche and Alnylam present positive results from the Phase II KARDIA-2 study of zilebesiran added to standard of care antihypertensives in patients with inadequately controlled hypertension
The KARDIA-2 study met its primary endpoint demonstrating additive, placebo-adjusted systolic blood pressure reductions of up to 12.1 mmHgat month three. These results were statistically significant and clinically meaningfulZilebesiran demonstrated an encouraging safety and tolerability profile when added to standard of care antihypertensives Basel, 7 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Alnylam today released detailed results from the Phase II KARDIA-2 study evaluating the efficacy and safety of a single subcutaneous dose of zilebesiran when added to one of three standard of care (SOC) antihypertensives. T...
Source: Roche Investor Update - April 7, 2024 Category: Pharmaceuticals Source Type: news
Distance to Neurologist, PCP May Explain Alzheimer Disease Disparities
FRIDAY, April 5, 2024 -- Distance to a neurologist and primary care physician may explain some of the disparities in Alzheimer disease and related dementia (AD/ADRD) outcomes, according to a study published online March 20 in Alzheimer ' s&... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 5, 2024 Category: Pharmaceuticals Source Type: news
